Reduced coronary flow reserve in familial hypercholesterolemia.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Nuclear Medicine

• Publication date

  1996-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 8970509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The risk of atherosclerotic vascular disease in subjects with xanthomatosis.

  2009cited by this paper
• Reversal of coronary atherosclerosis. Clinical promise as the basis for noninvasive management of coronary artery disease.

  1994cited by this paper
• Early Detection of Abnormal Coronary Flow Reserve in Asymptomatic Men at High Risk for Coronary Artery Disease Using Positron Emission Tomography

  1994cited by this paper
• Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium.

  1994cited by this paper
• Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction.

  1994cited by this paper
• Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function

  1993cited by this paper
• The Role of Nitric Oxide in Endothelium‐Dependent Vasodilation of Hypercholesterolemic Patients

  1993cited by this paper
• Influence of Age and Hemodynamics on Myocardial Blood Flow and Flow Reserve

  1993cited by this paper
• Influence of Serum Cholesterol and Other Coronary Risk Factors on Vasomotion of Angiographically Normal Coronary Arteries

  1993cited by this paper
• DIPYRIDAMOLE POTENTIATES ANTIAGGREGATING AND VASORELAXING EFFECTS OF ENDOTHELIUM-DERIVED RELAXING FACTOR BY THE INHIBITION OF CYCLIC GMP PHOSPHODIESTERASE

  1991cited by this paper
• Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide.

  1991cited by this paper
• Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine.

  1991cited by this paper
• Endothelial Function in Human Coronary Arteries In Vivo: Focus on Hypercholesterolemia

  1991cited by this paper
• Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.

  1991cited by this paper
• Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates.

  1990cited by this paper
• Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging.

  1990cited by this paper
• Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension.

  1990cited by this paper
• 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography.

  1989cited by this paper
• Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits.

  1989cited by this paper
• Development of coronary heart disease in familial hypercholesterolemia.

  1989cited by this paper
• Loss of Selective Endothelial Cell Vasoactive Functions Caused by Hypercholesterolemia in Pig Coronary Arteries

  1988cited by this paper
• Causes of death in patients with familial hypercholesterolemia.

  1986cited by this paper
• Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases.

  1976cited by this paper
• Neonatal diagnosis of familial type II hyperlipoproteinemia.

  1976cited by this paper
• Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor.

  1975cited by this paper
• Effects of coronary stenoses on coronary flow reserve and resistance.

  1974cited by this paper
• Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia

  1974cited by this paper
• Neonatal diagnosis of familial type-II hyperlipoproteinaemia.

  1973cited by this paper
• Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states.

  1969cited by this paper
• Coronary Disease in Familial Hypercholesterolemia

  1967cited by this paper

• Targeted Therapies for Microvascular Disease.

  2024cites this paper
• Targeted Therapies for Microvascular Disease.

  2024cites this paper
• Targeted Therapies for Microvascular Disease.

  2023cites this paper
• Sex- and age-specific normal values for automated quantitative pixel-wise myocardial perfusion cardiovascular magnetic resonance

  2022cites this paper
• Improving Detection of CAD and Prognosis with PET/CT Quantitative Absolute Myocardial Blood Flow Measurements.

  2022cites this paper
• Sex-Specific Differences in Coronary Blood Flow and Flow Velocity Reserve in Symptomatic Patients with Non-obstructive Disease.

  2019cites this paper
• Correction to: Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC

  2018cites this paper
• Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC

  2017cites this paper
• Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC

  2017cites this paper
• Coronary Microvascular Dysfunction　- Epidemiology, Pathogenesis, Prognosis, Diagnosis, Risk Factors and Therapy.

  2016cites this paper
• Kardiovaskuläre PET/CT in den USA

  2016cites this paper
• Severe familial hypercholesterolemia impairs the regulation of coronary blood flow and oxygen supply during exercise

  2016cites this paper
• Cardiac Syndrome X and Microvascular Angina

  2015cites this paper
• Coronary flow reserve estimated by positron emission tomography to diagnose significant coronary artery disease and predict cardiac events.

  2014cites this paper
• Etiopathogenesis of microvascular angina: caveats in our knowledge.

  2014cites this paper
• CMD in the Absence of Myocardial Diseases and Obstructive CAD

  2014cites this paper
• PET in Cardiovascular Diseases

  2013cites this paper
• Atorvastatin Treatment Improves Myocardial and Peripheral Blood Flow in Familial Hypercholesterolemia Subjects without Evidence of Coronary Atherosclerosis

  2013cites this paper
• Myocardial Flow Reserve Partially Recovered after Additional Intensive Anti-Hyperglycemic Therapy in Patients with Type 2 Diabetes

  2013cites this paper
• Why Quantify Myocardial Perfusion?

  2012cites this paper
• Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management.

  2011cites this paper
• PET and PET/CT in cardiovascular disease

  2011cites this paper
• Risk Evaluation for Coronary Artery Disease in Patients With Impaired Glucose Tolerance After a Successful Coronary Intervention

  2011cites this paper
• Cardiac PET/CT for the evaluation of known or suspected coronary artery disease.

  2011cites this paper
• Evaluation of coronary flow velocity reserve in homozygous familial hypercholesterolemia by transthoracic Doppler echocardiography and dual-source computed tomography.

  2010cites this paper
• Noninvasive Evaluation of Coronary Flow Velocity Reserve in Homozygous Familial Hypercholesterolemia by Transthoracic Doppler Echocardiography

  2010cites this paper
• Anatomy and physiology of coronary blood flow

  2010cites this paper
• Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.

  2010cites this paper
• Coronary vasomotor function assessed by positron emission tomography

  2010cites this paper
• PET/CT challenge for the non-invasive diagnosis of coronary artery disease.

  2010cites this paper
• Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve

  2010cites this paper
• Chapter 19 – Diagnosis and Prognosis in Cardiac Disease Using Cardiac PET Perfusion Imaging

  2010cites this paper
• Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location.

  2009cites this paper
• Quantification of myocardial blood flow: what is the clinical role?

  2009cites this paper
• Estudio de la función endotelial mediante tomografía por emisión de positrones en pacientes con hipercolesterolemia

  2008cites this paper
• Cardiac PET-CT and its Implementation into Clinical Practice

  2008cites this paper
• Low-dose of statin treatment improves cerebrovascular reactivity in patients with ischemic stroke: single photon emission computed tomography analysis.

  2008cites this paper
• Impaired coronary flow velocity reserve and aortic distensibility in patients with untreated hypercholesterolemia—an echocardiographic study

  2007cites this paper
• Quantifying Myocardial Perfusion for the Assessment of Preclinical CAD

  2007cites this paper
• Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

  2006cites this paper
• Myocardial blood flow measurement by PET: technical aspects and clinical applications.

  2005cites this paper
• Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease

  2005cites this paper
• PET coronary flow reserve

  2005cites this paper
• PET/CT: challenge for nuclear cardiology.

  2005cites this paper
• Relationship Between Hypercholesterolemia, Lipid‐Lowering Therapy and Coronary Flow Velocity Reserve Evaluated by Stress Transesophageal Echocardiography in Patients with a Negative Coronary Angiogram

  2004cites this paper
• Assessment of coronary flow reserve and microcirculation: A clinical perspective

  2004cites this paper
• Changes in Coronary Flow Reserve Assessed by Transthoracic Echocardiography after Lipid-Lowering Therapy in Patients with Hypercholesterolemia

  2004cites this paper
• Impaired myocardial vasodilatation during hyperaemic stress is improved by simvastatin but not by pravastatin in patients with hypercholesterolaemia.

  2004cites this paper
• Positron Emission Tomography of the Heart: Methodology, Findings in the Normal and the Diseased Heart, and Clinical Applications

  2004cites this paper
• Myocardial Perfusion Imaging

  2003cites this paper
• Impact of Diabetes Mellitus on Worsening of the Left Ven-tricular Ejection Fraction in Exercise-Gated 201Tl Myocardial Single Photon Emission Computed Tomography in Patients With Coronary Artery Disease

  2003cites this paper
• Impact of diabetes mellitus on worsening of the left ventricular ejection fraction in exercise-gated 201Tl myocardial single photon emission computed tomography in patients with coronary artery disease.

  2003cites this paper
• Impact of Diabetes Mellitus on Worsening of the Left Ventricular Ejection Fraction in Exercise-Gated 201 Tl Myocardial Single Photon Emission Computed Tomography in Patients With Coronary Artery Disease

  2003cites this paper
• Factors affecting coronary flow velocity reserv and its relations to aortic atherosclerosis

  2003cites this paper
• Recent progress in nuclear cardiology

  2002cites this paper
• Myocardial Blood Flow and Perfusion: Radionuclide Techniques

  2002cites this paper
• Reduced myocardial flow reserve in anatomically normal coronary arteries due to elevated baseline myocardial blood flow in men with old myocardial infarction

  2002cites this paper
• Impaired exercise-related myocardial uptake of technetium-99m-tetrofosmin in relation to coronary narrowing and diabetic state: assessment with quantitative single photon emission computed tomography.

  2001cites this paper
• Beyond the cholesterol profile: Monitoring therapeutic effectiveness of statin therapy

  2001cites this paper
• Quantification of limited augmentation of myocardial 99mTc-tetrofosmin uptake at exercise in stable coronary artery disease

  2001cites this paper
• Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance

  2001cites this paper
• Assessment of Vascular Reactivity with Positron Emission Tomography

  2001cites this paper
• Clinical Applications of Positron Emission Tomography in Coronary Atherosclerosis

  2000cites this paper
• Quantitative assessment of regional myocardial blood flow using oxygen-15-labelled water and positron emission tomography: a multicentre evaluation in Japan

  2000cites this paper
• Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia.

  2000cites this paper
• Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease.

  2000cites this paper
• Clinical applications of positron emission tomography in coronary atherosclerosis

  2000cites this paper
• PART II Vascular function and intervention

  2000cites this paper
• Lipoproteins and the endothelium: insights from clinical research.

  2000cites this paper
• Lipoproteins and the Endothelium: Insights from Clinical Research

  2000cites this paper
• PTCA but not atorvastatin normalises dipyri- damole induced myocardial perfusion and perfusion reserve in target vessel areas after 6 months. A randomised study using positron emission tomography

  2000cites this paper
• Clinical applications of positron emission tomography in coronary atherosclerosis

  2000cites this paper
• Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels.

  2000cites this paper
• Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy.

  1999cites this paper
• Gender differences in myocardial blood flow dynamics: lipid profile and hemodynamic effects.

  1999cites this paper
• Altered myocardial vasodilatation in patients with hypertriglyceridemia in anatomically normal coronary arteries.

  1998cites this paper
• [Methods for coronary functional assessment].

  1998cites this paper
• Hyperglycemia Rather Than Insulin Resistance Is Related to Reduced Coronary Flow Reserve in NIDDM

  1998cites this paper
• Methoden der funktionellen Koronardiagnostik

  1998cites this paper
• Impaired myocardial vasodilation during hyperemic stress with dipyridamole in hypertriglyceridemia.

  1998cites this paper
• Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus.

  1997cites this paper
• Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis.

  1996cites this paper